Scarica l'app Stockscreener
5.98
1.48%
-0.09
Dopo l'orario di chiusura:
6.01
0.03
+0.50%
Precedente Chiudi:
$6.07
Aprire:
$6
Volume 24 ore:
485.48K
Relative Volume:
0.64
Capitalizzazione di mercato:
$141.07M
Reddito:
-
Utile/perdita netta:
$-52.07M
Rapporto P/E:
-28.79
EPS:
-0.2077
Flusso di cassa netto:
$-44.93M
1 W Prestazione:
-17.63%
1M Prestazione:
-1.48%
6M Prestazione:
-3.70%
1 anno Prestazione:
-47.54%
Intervallo 1D:
$5.86
$6.0316
Intervallo di 1 settimana:
$5.82
$7.4375
Portata 52W:
$4.81
$13.88
Cybin Inc Stock (CYBN) Company Profile
Nome
Cybin Inc
Settore
Industria
Telefono
908 764 8385
Indirizzo
100 King Street West, Suite 5600, Toronto
Confronta CYBN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CYBN
Cybin Inc
|
5.98 | 302.92M | 0 | -52.07M | -44.93M | -0.2077 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cybin Inc Stock (CYBN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-13 | Iniziato | Guggenheim | Buy |
| 2021-11-19 | Downgrade | Maxim Group | Buy → Hold |
Cybin Inc Borsa (CYBN) Ultime notizie
Cybin to Release Q2 Financial Results and Business Update - The Globe and Mail
Is Cybin Inc. stock ready for a breakoutEarnings Overview Summary & Accurate Buy Signal Notifications - newser.com
How Cybin Inc. stock compares to industry benchmarks2025 Market Outlook & Daily Profit Maximizing Trade Tips - newser.com
What’s the recovery path for long term holders of Cybin Inc.Profit Target & Low Risk High Win Rate Stock Picks - newser.com
Can Cybin Inc. Common Shares stock surprise markets with earningsWeekly Profit Recap & Verified Technical Trade Signals - newser.com
Cybin (NYSEAMERICAN:CYBN) Stock Price Up 2%Still a Buy? - MarketBeat
Long term hold vs stop loss in Cybin Inc.Weekly Trend Report & Proven Capital Preservation Tips - newser.com
Cybin Bets Big On Psychedelics With Phase 3 Trials Underway - Finimize
Is Cybin Inc. stock oversold or undervaluedJuly 2025 Institutional & Accurate Technical Buy Alerts - newser.com
[6-K] CYBIN INC. Current Report (Foreign Issuer) | CYBN SEC FilingForm 6-K - Stock Titan
Cybin to Host Q2 2025 Financial Results Conference Call on November 13 - citybuzz -
Cybin Inc. (CYBN) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Cybin to Announce Second Quarter Financial Results and Provide Business Update on November 13, 2025 - Business Wire
Cybin Inc. to Present at Guggenheim Healthcare Innovation Conference Amid Phase 3 Mental Health Drug Development - citybuzz -
Will Cybin Inc. (R7E) stock gain from green policies2025 Pullback Review & Accurate Intraday Trading Signals - newser.com
What market sentiment indicators show for Cybin Inc. Common Shares stockWeekly Investment Recap & Fast Entry Momentum Trade Alerts - newser.com
Will Cybin Inc. stock gain from strong economyShort Setup & Weekly High Conviction Trade Ideas - newser.com
Will Cybin Inc. Common Shares stock top growth indexesWeekly Gains Summary & Technical Confirmation Alerts - fcp.pa.gov.br
Can Cybin Inc. stock deliver surprise earnings beatRisk Management & Real-Time Buy Signal Alerts - newser.com
Earnings Recap: Is Cybin Inc. stock cheap at current valuationWeekly Trading Summary & Advanced Technical Signal Analysis - fcp.pa.gov.br
Live market analysis of Cybin Inc.Weekly Trend Recap & Consistent Profit Alerts - newser.com
Cybin to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference - Investing News Network
How Cybin Inc. stock compares to growth peersMarket Activity Summary & Consistent Income Trade Recommendations - newser.com
Can technical indicators confirm Cybin Inc.’s reversalMarket Sentiment Review & Growth Focused Stock Pick Reports - newser.com
Why Cybin Inc. Common Shares stock is a strong analyst pickJuly 2025 Fed Impact & High Conviction Investment Ideas - newser.com
Custom strategy builders for tracking Cybin Inc.Quarterly Market Review & Long-Term Growth Portfolio Plans - newser.com
Using Python tools to backtest Cybin Inc. strategiesJuly 2025 Setups & High Conviction Investment Ideas - newser.com
Will Cybin Inc. (R7E) stock profit from automation wave2025 Price Momentum & Growth Oriented Trade Recommendations - newser.com
What hedge fund activity signals for Cybin Inc. stockWeekly Stock Summary & Safe Entry Zone Identification - newser.com
[SCHEDULE 13G] CYBIN INC. SEC Filing - Stock Titan
United States Psychedelic Drugs Market 2025: Industry - openPR.com
Cybin Inc. (CYBN.NE) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Cybin Chief Medical Officer to Present at 2025 Milken Institute Health Summit - citybuzz -
Cybin Inc Azioni (CYBN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.44%
0.70%
Capitalizzazione:
|
Volume (24 ore):